Cnx Therapeutics Limited

Cnx Therapeutics Limited

Trading as: CNX Therapeutics
#03363032 Active

Dedicated to the treatment of CNS disorders

Founded: 01/05/1997
Industries: Wholesale of pharmaceutical goods
Location: London

Financial Snapshot

Last accounts made up to 31 March 2024
Next accounts due 31 December 2025 (7 months)
Cash in Bank £6.9m
↑ 571%
Turnover £26.76m
↑ 115%
EBITDA £6.68m
↑ -547%
Gross Profit £17.32m
↑ 153%
Total Liabilities £63.41m
↑ 138%
Employees 27
↑ 50%

Directors

Role:
Director
Appointed:
15/08/2024
Nationality:
British
Age:
43 years
Role:
Chief Executive Officer
Appointed:
12/01/2022
Nationality:
British
Age:
55 years

People with Significant Control

Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors
Notified On:
17/08/2021
Nationality:
United Kingdom
Mar 2024Mar 2023Mar 2022
Income Statement
Turnover
Export Revenue
Sales
Other Operating Income
Other Operating Items
Cost of Sales
Raw Materials & Consumables
Gross Profit
Admin Expenses
Other Operating Charges
Depreciation
R&D Expenses
Operating Profit
EBITDA
Financial Revenue
Financial Expenses
Financial Profit/Loss
Interest Paid
Extraordinary Revenue
Extraordinary Expenses
Net Extraordinary Items
Pre-Tax Profit
Tax
Profit After Tax
Retained Profit
Balance Sheet
Non-Current Assets
Intangible Assets
Tangible Fixed Assets
Other Non-Current Assets
Current Assets
Stock
Debtors
Cash in Hand
Other Current Assets
Called Up Share Capital
P&L Account Reserve
Shareholder Funds
Other Shareholder Funds
Provisions
Long Term Debt
Creditors (> 1 year)
Other Non-Current Liabilities
Short Term Debt
Creditors
Creditors (< 1 year)
Other Current Liabilities
Key Metrics
Net Assets
Net Current Assets
Total Assets Less Current Liabilities
Working Capital
Enterprise Value
Added Value
Cashflow Before D&A
Other Information
Staff Costs
Number of Employees
1 shareholder available
Shareholder 1
Shares:
Percentage:
Filing Date:
Shareholder 2
Shares:
Percentage:
Filing Date:
Shareholder 3
Shares:
Percentage:
Filing Date:

Charges

2 charges registered
Ares Management Limited (The “Security Agent”) Outstanding
Created 23/11/2023

1. trademark text “cardioxane” registered with trademark number UK00906441737 under class 5.. 2. tra...

#033630320002 Negative Pledge
Nordea Property Investments (UK) Satisfied
Created 05/05/2004

Initial deposit £76,375. see the mortgage charge document for full details.

Properties

No property information available

2 issuances recorded

Total Amount Raised (Valid Issuances)

Shares Issued (Valid Issuances)

Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:
Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:

Grants

No grant information available

Group Structure

Government Council Contracts Beta

No council contracts found

Company Filings

06/09/2024 Accounts

Accounts With Accounts Type Full

16/08/2024 Officers

Appoint Person Director Company With Name Date

25/07/2024 Officers

Termination Director Company With Name Termination Date

14/05/2024 Confirmation Statement

Confirmation Statement With Updates

24/11/2023 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

22/11/2023 Accounts

Accounts With Accounts Type Small

03/08/2023 Capital

Capital Allotment Shares